Malignant glioma: Who benefits from adjuvant chemotherapy? Academic Article uri icon

Overview

MeSH Major

  • Brain Neoplasms
  • Chemotherapy, Adjuvant
  • Glioma

abstract

  • We combined two randomized prospective Brain Tumor Study Group data sets to analyze the effects of prognostic factors on survival by treatment group. Adjuvant chemotherapy increased long-term survival regardless of prognostic factors. Pathological review revealed that oligo dendrogliomas were overrepresented among long-term survivors independent of therapy. Prognostic factors do not predict benefit from adjuvant nitrosourea in malignant gliomas, and long-term survival with chemotherapy is not explained by oligodendroglial tumors.

publication date

  • October 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/ana.410440418

PubMed ID

  • 9778271

Additional Document Info

start page

  • 691

end page

  • 5

volume

  • 44

number

  • 4